FFPNX | MGFSX | FFPNX / MGFSX | |
Total Expense Ratio | 0.51 | 1.03 | 50% |
Annual Report Gross Expense Ratio | 0.51 | 1.03 | 50% |
Fund Existence | 5 years | 21 years | - |
Gain YTD | 15.551 | 9.147 | 170% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 159B | 164M | 96,951% |
Annual Yield % from dividends | 0.70 | 0.00 | - |
Returns for 1 year | 13.93 | -3.28 | -425% |
Returns for 3 years | 36.58 | -20.81 | -176% |
Returns for 5 years | N/A | -27.95 | - |
Returns for 10 years | N/A | -29.03 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FRBRX | 141.34 | 1.72 | +1.23% |
Franklin Biotechnology Discovery R6 | |||
PSPFX | 4.56 | 0.02 | +0.44% |
US Global Investors Global Res | |||
JAREX | 14.15 | 0.04 | +0.28% |
Easterly Global Real Estate A | |||
RSOOX | 39.89 | -0.08 | -0.20% |
Columbia Dividend Opportunity R | |||
LCEFX | 19.33 | -0.09 | -0.46% |
Invesco Diversified Dividend R6 |